Charles Messan Atisso
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 2%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 20
- Diabetes Management and Research 2
-
- Metabolism, Diabetes, and Cancer 7
- Co-authors
- José Gerardo González‐González (2 shared papers)Whitney Sealls (2 shared papers)Jessie L. Fahrbach (2 shared papers)Kathleen Marie Dungan (2 shared papers)Thomas M. Forst (2 shared papers)Mark C Lakshmanan (7 shared papers)Thomas Blevins (4 shared papers)Richard F. Arakaki (4 shared papers)
- Journals
- Cardiovascular Diabetology (3 papers)Diabetes Obesity and Metabolism (3 papers)The Lancet (3 papers)Diabetes Care (2 papers)Diabetes (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Charles Messan Atisso
20 papers receiving 4.1k citations
Charles Messan Atisso's Hit Papers
Peers
Comparison fields: 5 of 84
- Endocrinology, Diabetes and Metabolism 3.4k
- Pharmacology 541
- Surgery 811
- Nephrology 127
- Cardiology and Cardiovascular Medicine 350
Countries citing papers authored by Charles Messan Atisso
This map shows the geographic impact of Charles Messan Atisso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Messan Atisso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Messan Atisso more than expected).
Fields of papers citing papers by Charles Messan Atisso
This network shows the impact of papers produced by Charles Messan Atisso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Messan Atisso. The network helps show where Charles Messan Atisso may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Messan Atisso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2307 |
| 2 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 492 |
| 3 | Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial Hit paper breakdown → | 2014 | 422 |
| 4 | 2014 | 339 | |
| 5 | 2020 | 228 | |
| 6 | 2017 | 148 | |
| 7 | 2020 | 97 | |
| 8 | 2016 | 53 | |
| 9 | 2021 | 49 | |
| 10 | 2020 | 28 | |
| 11 | 2021 | 20 | |
| 12 | 2020 | 12 | |
| 13 | 2023 | 10 | |
| 14 | 2013 | 6 | |
| 15 | 2019 | 5 | |
| 16 | 2014 | 4 | |
| 17 | 2020 | 3 | |
| 18 | 2020 | 2 | |
| 19 | 2013 | 1 | |
| 20 | 2024 | 1 |
About Charles Messan Atisso
Charles Messan Atisso is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Pharmacology, Immunology and Cardiology and Cardiovascular Medicine, having authored 21 papers that have together received 4.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (20 papers), Metabolism, Diabetes, and Cancer (7 papers), Diabetes Management and Research (2 papers), Pharmacology and Obesity Treatment (2 papers), Gastric Cancer Management and Outcomes (1 paper), Lipoproteins and Cardiovascular Health (1 paper), Antiplatelet Therapy and Cardiovascular Diseases (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.4k citations), Pharmacology (541 citations), Surgery (811 citations), Nephrology (127 citations) and Cardiology and Cardiovascular Medicine (350 citations). Charles Messan Atisso has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include José Gerardo González‐González, Whitney Sealls, Jessie L. Fahrbach, Kathleen Marie Dungan, Thomas M. Forst, Mark C Lakshmanan, Thomas Blevins, Richard F. Arakaki, Carol Wysham and Pedro García. Their work appears in journals such as Cardiovascular Diabetology, Diabetes Obesity and Metabolism, The Lancet, Diabetes Care and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.